Viscero - ECG Vest
Wearable health technology
An arrhythmia is an abnormal heartbeat that can be harmless or life-threatening. The most common type is atrial fibrillation (AFib), where the upper heart chambers contract irregularly. This can lead to blood clots, stroke, heart failure, and other heart-related complications. It's estimated that annually as many as 12.1 million people in the US will have AFib (Centers for Disease Control and Prevention) by 2030. We should be empowered to monitor our wellbeing every day, with consumer-friendly, preventative solutions. Viscero is a revolutionary wearable ECG monitoring device, that captures and communicates diagnostic quality data effortlessly.
Development Time
13 - 24 months
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Consumer / User, Trade / Industry